What are the recent financial highlights of KRSNAA DIAGNOSTICS LTD?

KRSNAA DIAGNOSTICS LTD recently reported a total revenue of ₹697.37 Cr and a net profit margin of 10.85%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of KRSNAA DIAGNOSTICS LTD?

KRSNAA DIAGNOSTICS LTD offers a dividend yield of 0.33%, with a dividend rate of ₹2.5 per share.

What are the key financial metrics of KRSNAA DIAGNOSTICS LTD?

Key financial metrics include a trailing P/E ratio of 31.79431, forward P/E of 18.013885, book value of ₹260.432, price-to-book ratio of 2.7895956, and a market capitalization of ₹23.54 billion.

What does KRSNAA DIAGNOSTICS LTD do?

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers various diagnostic services, including radiology, pathology, and teleradiology services. The company also provides health packages, such as diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, infection screening, fever profiles, etc. It serves its services to public and private hospitals, medical colleges, and community health centers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Krsnaa

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Krsnaa

Latest updates related to Krsnaa

Sr No.	Title	Sentiment
1	Q4 Results Today: Ujjivan SFB, Krsnaa Diagnostics, Patel Engineering among 55 companies to post earnings on May 18 Mint	🔄
2	Thermax, Jubilant Foods, Krsnaa & Tube Investments: 4 stock picks by SMC Global Business Today	🔄
3	Q4 Results Today: Ujjivan SFB, Krsnaa Diagnostics, Patel Engineering among 55 companies to post earnings on May 18 Mint	🔄
4	Krsnaa Diagnost Standalone December 2024 Net Sales at Rs 165.16 crore, up 8.98% Y-o-Y Moneycontrol	🔄
5	Krsnaa Diagnostics consolidated net profit rises 49.73% in the December 2024 quarter Business Standard	🔄
6	Krsnaa Diagnostics picks up stake in PPP hospital operator Apulki Healthcare The Economic Times	🔄
7	Krsnaa Diagnostics makes strategic investment in Apulki Healthcare BusinessLine	🔄
8	Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare ETHealthWorld	🔄
9	Krsnaa Diagnostics inks pacts to expand radiology and pathology services in Ranchi CNBCTV18	🔄
10	Thermax, Jubilant Foods, Krsnaa & Tube Investments: 4 stock picks by SMC Global Business Today	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Loading...

Loading...

Stock News - Krsnaa

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Credit ratings

Concalls

Explore More Stocks